Fulong Li

Title: Fulong Li: Innovator in Pharmaceutical Chemistry

Introduction

Fulong Li is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on naphthyridine derivatives. His research focuses on developing compounds that have the potential to treat various medical conditions.

Latest Patents

Fulong Li holds a patent for a compound titled "1,4-dihydro-naphthyridine derivative and pharmaceutical composition and use thereof." This patent describes 1,4-dihydro-naphthyridine derivatives that can inhibit acetylcholinesterase activity and prevent extracellular calcium from entering cells via calcium channels. These dual-activity compounds are of potential importance in the pharmaceutical industry and can be utilized in the development of drugs for treating cardiovascular diseases, cerebrovascular diseases, and dementia. He has 1 patent to his name.

Career Highlights

Fulong Li is currently associated with Jiangsu Simovay Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential applications in the medical field, particularly in addressing critical health issues.

Collaborations

Fulong Li collaborates with notable colleagues, including Rong Chen and Lin Feng, who contribute to his research endeavors. Their combined expertise enhances the innovative potential of their projects.

Conclusion

Fulong Li's contributions to pharmaceutical chemistry exemplify the impact of innovative research on healthcare. His work on naphthyridine derivatives holds promise for developing new treatments for serious medical conditions.